Eastwood Bio-Medical Canada Inc (EBM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) has a cash flow conversion efficiency ratio of -0.001x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$2.26K ≈ $1.63K USD) by net assets (CA$-1.72 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Eastwood Bio-Medical Canada Inc for the company's overall valuation and market capitalisation.
Eastwood Bio-Medical Canada Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Eastwood Bio-Medical Canada Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eastwood Bio-Medical Canada Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their cash flow conversion efficiency. Explore EBM cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
-0.131x |
|
GrowGeneration Corp
NASDAQ:GRWG
|
0.010x |
|
Collins Co Ltd
TW:2906
|
0.004x |
|
TDG Gold Corp
V:TDG
|
-0.226x |
|
Fullerton Technology Co Ltd
TW:6136
|
0.007x |
|
Sam Holdings Corp
VN:SAM
|
0.114x |
|
ÖKOWORLD AG
XETRA:VVV3
|
0.008x |
|
Hf Foods Group Inc
NASDAQ:HFFG
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Eastwood Bio-Medical Canada Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Eastwood Bio-Medical Canada Inc from 2013 to 2025. View Eastwood Bio-Medical Canada Inc stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$19.30K ≈ $13.96K |
-0.012x | -200.95% |
| 2024-10-31 | CA$-1.30 Million ≈ $-937.99K |
CA$-15.22K ≈ $-11.01K |
0.012x | -41.57% |
| 2023-10-31 | CA$-840.80K ≈ $-608.22K |
CA$-16.89K ≈ $-12.22K |
0.020x | +37.61% |
| 2022-10-31 | CA$-294.20K ≈ $-212.82K |
CA$-4.29K ≈ $-3.11K |
0.015x | -98.19% |
| 2021-10-31 | CA$-144.32K ≈ $-104.40K |
CA$-116.21K ≈ $-84.07K |
0.805x | +168.15% |
| 2020-10-31 | CA$459.27K ≈ $332.23K |
CA$-542.69K ≈ $-392.58K |
-1.182x | -770.13% |
| 2019-10-31 | CA$1.31 Million ≈ $948.87K |
CA$-178.13K ≈ $-128.86K |
-0.136x | +43.59% |
| 2018-10-31 | CA$1.89 Million ≈ $1.37 Million |
CA$-454.79K ≈ $-328.99K |
-0.241x | -87.18% |
| 2017-10-31 | CA$2.76 Million ≈ $2.00 Million |
CA$-355.28K ≈ $-257.00K |
-0.129x | -34.57% |
| 2016-10-31 | CA$3.21 Million ≈ $2.32 Million |
CA$-306.58K ≈ $-221.77K |
-0.096x | -31.67% |
| 2015-10-31 | CA$3.73 Million ≈ $2.70 Million |
CA$-270.51K ≈ $-195.68K |
-0.073x | -118.34% |
| 2014-10-31 | CA$3.99 Million ≈ $2.88 Million |
CA$1.58 Million ≈ $1.14 Million |
0.396x | -67.40% |
| 2013-10-31 | CA$-208.29K ≈ $-150.68K |
CA$-252.88K ≈ $-182.93K |
1.214x | -- |
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more